Evaluation of anionic half generation 3.5-6.5 poly(amidoamine) dendrimers as delivery vehicles for the active component of the anticancer drug cisplatin
Gordon J. Kirkpatrick, Jane A. Plumb, Oliver B. Sutcliffe, David J. Flint, Nial J. Wheate
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Evaluation of anionic half generation 3.5-6.5 poly(amidoamine) dendrimers as delivery vehicles for the active component of the anticancer drug cisplatin'. Together they form a unique fingerprint.